Theravance Biopharma (TBPH) Shares Outstanding (Diluted) (2017 - 2026)
Powered by 
Analysis
Theravance Biopharma (TBPH) Shares Outstanding (Diluted) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.32 Bn | 131.47 Bn | 2.84 Bn | 255.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.67 Bn | 77.67 Bn | 3.93 Bn | 106.00 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.33 Bn | 1.37 Bn | 66.03 Mn |
| 4 | Moderna | 58.21 Bn | 53.07 Bn | 52.00 Mn | 398.00 Mn |
| 5 | Revolution Medicines | 44.17 Bn | 44.17 Bn | - | 210.89 Mn |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 115.80 Mn |
| 7 | Alnylam Pharmaceuticals | 35.25 Bn | 31.94 Bn | 992.69 Mn | 138.28 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - | 556.90 Mn |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Theravance Biopharma | 882.47 Mn | 494.82 Mn | - | 51.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 51.67 Mn |
| Mar 31, 2026 | 51.28 Mn |
| Dec 31, 2025 | 51.51 Mn |
| Sep 30, 2025 | 51.91 Mn |
| Jun 30, 2025 | 50.73 Mn |
| Mar 31, 2025 | 49.71 Mn |
| Dec 31, 2024 | 48.85 Mn |
| Sep 30, 2024 | 49.04 Mn |
| Jun 30, 2024 | 48.75 Mn |
| Mar 31, 2024 | 48.28 Mn |
| Dec 31, 2023 | 55.30 Mn |
| Sep 30, 2023 | 52.36 Mn |
| Jun 30, 2023 | 56.68 Mn |
| Mar 31, 2023 | 62.93 Mn |
| Dec 31, 2022 | 73.59 Mn |
| Sep 30, 2022 | 75.52 Mn |
| Jun 30, 2022 | 76.27 Mn |
| Mar 31, 2022 | 75.25 Mn |
| Dec 31, 2021 | 69.46 Mn |
| Sep 30, 2021 | 73.57 Mn |